Kintayl Capital LP Sells 410,792 Shares of Sotera Health Company (NASDAQ:SHC)

Kintayl Capital LP cut its position in shares of Sotera Health Company (NASDAQ:SHC - Free Report) by 49.5% during the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 419,796 shares of the company's stock after selling 410,792 shares during the period. Sotera Health accounts for 3.5% of Kintayl Capital LP's holdings, making the stock its 12th biggest position. Kintayl Capital LP owned about 0.15% of Sotera Health worth $4,895,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Victory Capital Management Inc. lifted its position in shares of Sotera Health by 5.7% in the first quarter. Victory Capital Management Inc. now owns 57,655 shares of the company's stock valued at $672,000 after acquiring an additional 3,106 shares in the last quarter. Principal Financial Group Inc. grew its stake in Sotera Health by 0.3% during the 1st quarter. Principal Financial Group Inc. now owns 352,388 shares of the company's stock worth $4,109,000 after purchasing an additional 1,037 shares in the last quarter. Teacher Retirement System of Texas purchased a new stake in shares of Sotera Health in the 1st quarter valued at approximately $266,000. New York State Teachers Retirement System increased its holdings in shares of Sotera Health by 1.9% in the 1st quarter. New York State Teachers Retirement System now owns 59,273 shares of the company's stock valued at $691,000 after acquiring an additional 1,100 shares during the last quarter. Finally, Farther Finance Advisors LLC boosted its holdings in shares of Sotera Health by 4,881.9% in the 1st quarter. Farther Finance Advisors LLC now owns 6,327 shares of the company's stock valued at $70,000 after buying an additional 6,200 shares in the last quarter. Institutional investors and hedge funds own 91.03% of the company's stock.

Sotera Health Stock Up 0.0%

SHC traded up $0.00 on Thursday, reaching $11.23. The company's stock had a trading volume of 652,770 shares, compared to its average volume of 1,231,414. Sotera Health Company has a 1 year low of $9.53 and a 1 year high of $17.08. The business's 50 day moving average is $11.97 and its 200 day moving average is $12.23. The company has a debt-to-equity ratio of 5.55, a current ratio of 2.46 and a quick ratio of 2.19. The stock has a market cap of $3.19 billion, a price-to-earnings ratio of 140.71 and a beta of 1.81.

Sotera Health (NASDAQ:SHC - Get Free Report) last released its earnings results on Thursday, May 1st. The company reported $0.14 EPS for the quarter, beating the consensus estimate of $0.12 by $0.02. Sotera Health had a return on equity of 41.08% and a net margin of 2.24%. The company had revenue of $254.52 million during the quarter, compared to analysts' expectations of $245.56 million. During the same period in the prior year, the business posted $0.13 EPS. The business's revenue was up 2.6% on a year-over-year basis. As a group, research analysts forecast that Sotera Health Company will post 0.61 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

SHC has been the subject of a number of research reports. Piper Sandler reduced their target price on shares of Sotera Health from $15.00 to $13.00 and set a "neutral" rating for the company in a report on Wednesday, April 23rd. Barclays lowered their price target on shares of Sotera Health from $15.00 to $13.00 and set an "overweight" rating on the stock in a research note on Tuesday, June 24th. The Goldman Sachs Group raised Sotera Health from a "neutral" rating to a "buy" rating and boosted their price target for the stock from $14.00 to $17.00 in a research note on Monday, May 5th. Finally, Wall Street Zen raised shares of Sotera Health from a "hold" rating to a "buy" rating in a research note on Saturday, June 28th. One analyst has rated the stock with a hold rating and five have issued a buy rating to the company. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $16.00.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.